Literature DB >> 1354267

Regulated adenovirus mRNA 3'-end formation in a coupled in vitro transcription-processing system.

S I Wilson-Gunn1, J E Kilpatrick, M J Imperiale.   

Abstract

The adenovirus major late transcription unit encodes five poly(A) sites whose use during infection is regulated. Early in the infection, the 5'-most site, L1, is used preferentially, whereas late in infection, all sites are used equivalently. Previous in vivo experiments indicated that regulatory sequences flank the AAUAAA and GU-rich elements of the L1 poly(A) site. We have developed an in vitro coupled transcription-processing system for studying the function of these regulatory sequences in HeLa cell nuclear extracts. The in vitro analysis using this system shows that predominant use of the L1 poly(A) site, as mediated by the upstream regulatory sequence, is independent of transcription. Furthermore, the reaction conditions are favorable to both 3'-end processing and splicing, making this system generally useful for the study of posttranscriptional processes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354267      PMCID: PMC289098     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  In vitro polyadenylation is stimulated by the presence of an upstream intron.

Authors:  M Niwa; S D Rose; S M Berget
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

2.  Modulation of alternative splicing of adenoviral E1A transcripts: factors involved in the early-to-late transition.

Authors:  R Gattoni; K Chebli; M Himmelspach; J Stévenin
Journal:  Genes Dev       Date:  1991-10       Impact factor: 11.361

3.  Sequences regulating temporal poly(A) site switching in the adenovirus major late transcription unit.

Authors:  J D DeZazzo; E Falck-Pedersen; M J Imperiale
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

4.  The human immunodeficiency virus type 1 polyadenylylation signal: a 3' long terminal repeat element upstream of the AAUAAA necessary for efficient polyadenylylation.

Authors:  A Valsamakis; S Zeichner; S Carswell; J C Alwine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

5.  Adenovirus and minute virus of mice DNAs are localized at the nuclear periphery.

Authors:  P T Moen; E Fox; J W Bodnar
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

6.  Steps in the processing of Ad2 mRNA: poly(A)+ nuclear sequences are conserved and poly(A) addition precedes splicing.

Authors:  J R Nevins; J E Darnell
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

7.  Adenovirus terminal protein mediates both nuclear matrix association and efficient transcription of adenovirus DNA.

Authors:  J Schaack; W Y Ho; P Freimuth; T Shenk
Journal:  Genes Dev       Date:  1990-07       Impact factor: 11.361

8.  A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro.

Authors:  H Ge; J L Manley
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

9.  Elements involved in an in vitro block to transcription elongation at the end of the L1 mRNA family of adenovirus 2.

Authors:  O Resnekov; R Pruzan; Y Aloni
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

10.  DNA template effect on RNA splicing: two copies of the same gene in the same nucleus are processed differently.

Authors:  G Adami; L E Babiss
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

View more
  10 in total

1.  3' Processing and termination of mouse histone transcripts synthesized in vitro by RNA polymerase II.

Authors:  X Gu; W F Marzluff
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

2.  Sequence-mediated regulation of adenovirus gene expression by repression of mRNA accumulation.

Authors:  J C Prescott; L Liu; E Falck-Pedersen
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

3.  Regulation of herpes simplex virus poly (A) site usage and the action of immediate-early protein IE63 in the early-late switch.

Authors:  F McGregor; A Phelan; J Dunlop; J B Clements
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  Sequence elements upstream of the 3' cleavage site confer substrate strength to the adenovirus L1 and L3 polyadenylation sites.

Authors:  J Prescott; E Falck-Pedersen
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

5.  Upstream and downstream cis-acting elements for cleavage at the L4 polyadenylation site of adenovirus-2.

Authors:  A Sittler; H Gallinaro; M Jacob
Journal:  Nucleic Acids Res       Date:  1994-01-25       Impact factor: 16.971

6.  Sequences regulating poly(A) site selection within the adenovirus major late transcription unit influence the interaction of constitutive processing factors with the pre-mRNA.

Authors:  G M Gilmartin; S L Hung; J D DeZazzo; E S Fleming; M J Imperiale
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

7.  Promoter-proximal poly(A) sites are processed efficiently, but the RNA products are unstable in the nucleus.

Authors:  J M Scott; M J Imperiale
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

8.  Characterization of chimeric full-length molecular clones of Aleutian mink disease parvovirus (ADV): identification of a determinant governing replication of ADV in cell culture.

Authors:  M E Bloom; B D Berry; W Wei; S Perryman; J B Wolfinbarger
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Relative roles of signals upstream of AAUAAA and promoter proximity in regulation of human immunodeficiency virus type 1 mRNA 3' end formation.

Authors:  J D DeZazzo; J M Scott; M J Imperiale
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

10.  Poly(A) site selection in the yeast Ty retroelement requires an upstream region and sequence-specific titratable factor(s) in vitro.

Authors:  W Hou; R Russnak; T Platt
Journal:  EMBO J       Date:  1994-01-15       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.